Bristol-Myers Squibb
Last updated on 2015-01-03T21:55+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| specialist | 2.44% | EN | 10/10/2017 |
| rival | 26.83% | EN | 16/02/2017 |
| leader | 63.41% | EN | 31/07/2016 |
| chief executive officer | 2.44% | EN | 31/01/2012 |
| rival | 4.88% | PT | 22/03/2006 |
| Names | Lang | Count |
|---|---|---|
| Bristol-Myers Squibb | EN | 61.87% |
| Bristol-Myers Squibb | FR | 9.18% |
| Bristol Myers Squibb | EN | 4.38% |
| Bristol-Myers Squibb | PT | 2.70% |
| Bristol-Myers Squibb | ES | 2.22% |
| Bristol-Myers Squibb | DE | 2.16% |
| Bristol-Myers Squibb | IT | 2.01% |
| Bristol-Myers Squibb | PL | 2.01% |
| Bristol-Myers Squibb | HR | 1.98% |
| Bristol-Myers Squibb | SV | 1.98% |
| Bristol-Myers Squibb | EU | 1.98% |
| Bristol-Myers Squibb | ZH | 1.98% |
| Bristol Myers Squibb | FR | 0.97% |
| Bristol Myers-Squibb | EN | 0.88% |
| Bristol-Meyers Squibb | EN | 0.73% |
| Bristol Myers Squibb | ES | 0.55% |
| Bristol Myers Squibb | RO | 0.52% |
| Bristol-Meyers Squibb | FR | 0.27% |
| Bristol Meyers Squibb | EN | 0.24% |
| Bristol Myers-Squibb | DE | 0.21% |
| Bristol Myers-Squibb | FR | 0.21% |
| Bristol Myers Squibb | PT | 0.21% |
| BRISTOL-MYERS SQUIBB | FR | 0.18% |
| BRISTOL MYERS SQUIBB | FR | 0.12% |
| Bristol-Myers-Squibb | EN | 0.12% |
| Bristol-Myers-Squibb | FR | 0.09% |
| BRISTOL-Myers Squibb | FR | 0.03% |
| Bristol-Myers-Squibb | EU | 0.03% |
| Bristol Meyers Squibb | FR | 0.03% |
| Bristol Myers Squibb | DE | 0.03% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 6.95% |
| Pfizer Inc | 3.83% |
| Wall Street | 2.11% |
| Eli Lilly | 2.01% |
 | Commission | 1.91% |
| Novartis | 1.81% |
| Reuters Group | 1.71% |
| 1.61% | |
| Dow Jones | 1.31% |
| Drug Administration | 1.31% |
| European Union | 1.21% |
| Risk Factors | 1.01% |
| Labor Department | 0.91% |
| Labor | 0.91% |
| Association | 0.91% |
| British | 0.91% |
| World Health Organization | 0.81% |
| Becton Dickinson | 0.81% |
| Boehringer Ingelheim | 0.81% |
| Pharmaceuticals Inc | 0.70% |
| GlaxoSmithKline | 0.70% |
| Microsoft | 0.70% |
| Novo Nordisk | 0.70% |
| Senate Majority | 0.60% |
| Mitch McConnell | 0.60% |
| SA | 0.60% |
| Roy Blunt | 0.60% |
| Cancer Research | 0.60% |
| Donald Trump | 0.60% |
| 0.60% |
| Type | Entity Name | Score |
|---|---|---|
| Eli Lilly | 0.0195 |
| Pfizer Inc | 0.0186 |
| Sabine Maier | 0.0182 |
| Jim Gale | 0.0175 |
| Novartis | 0.0168 |
| Adam Kelliher | 0.0143 |
| Gerry McQuade | 0.0125 |
| Ken Kobayashi | 0.011 |
| Inc | 0.0106 |
| Thomas Coughlin | 0.0089 |
| Drug Administration | 0.0088 |
| Risk Factors | 0.0088 |
| Wall Street | 0.0082 |
| Becton Dickinson | 0.008 |
| Boehringer Ingelheim | 0.008 |
| Dow Jones | 0.0077 |
| Bill Newell | 0.0076 |
| Novo Nordisk | 0.0071 |
| Labor Department | 0.0068 |
| Pharmaceuticals Inc | 0.0065 |
| GlaxoSmithKline | 0.0064 |
| Cancer Research | 0.0059 |
| Roy Blunt | 0.0058 |
| John Graziano | 0.0057 |
| Ludwig Hantson | 0.0053 |
| Helen Torley | 0.0052 |
| John Oyler | 0.0052 |
| Celgene Corporation | 0.0051 |
| Jim Woodgett | 0.005 |
| Charles Gore | 0.0048 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Wednesday, August 12, 2020
3:44:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 